These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 23348997)
1. Degradation kinetics of atorvastatin under stress conditions and chemical analysis by HPLC. Oliveira MA; Yoshida MI; Belinelo VJ; Valotto RS Molecules; 2013 Jan; 18(2):1447-56. PubMed ID: 23348997 [TBL] [Abstract][Full Text] [Related]
2. Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products. Chaudhari BG; Patel NM; Shah PB Chem Pharm Bull (Tokyo); 2007 Feb; 55(2):241-6. PubMed ID: 17268096 [TBL] [Abstract][Full Text] [Related]
3. Isolation and structure determination of oxidative degradation products of atorvastatin. Kracun M; Kocijan A; Bastarda A; Grahek R; Plavec J; Kocjan D J Pharm Biomed Anal; 2009 Dec; 50(5):729-36. PubMed ID: 19615842 [TBL] [Abstract][Full Text] [Related]
4. Validation of HPLC method for determination of atorvastatin in tablets and for monitoring stability in solid phase. Stanisz B; Kania L Acta Pol Pharm; 2006; 63(6):471-6. PubMed ID: 17438862 [TBL] [Abstract][Full Text] [Related]
5. Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug products. Chaudhari BG; Patel NM; Shah PB; Patel LJ; Patel VP J AOAC Int; 2007; 90(6):1539-46. PubMed ID: 18193730 [TBL] [Abstract][Full Text] [Related]
6. Stability-indicating high-performance liquid chromatographic assay of atorvastatin with fluorescence detection. Khedr A J AOAC Int; 2007; 90(6):1547-53. PubMed ID: 18193731 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe. Goel A; Baboota S; Sahni JK; Srinivas KS; Gupta RS; Gupta A; Semwal VP; Ali J J Chromatogr Sci; 2013 Mar; 51(3):222-8. PubMed ID: 22865836 [TBL] [Abstract][Full Text] [Related]
8. Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets. Kadav AA; Vora DN J Pharm Biomed Anal; 2008 Sep; 48(1):120-6. PubMed ID: 18583084 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets. Hassan SA; Elzanfaly ES; El-Zeany SB; Salem MY Acta Pharm; 2016 Dec; 66(4):479-490. PubMed ID: 27749253 [TBL] [Abstract][Full Text] [Related]
10. Estimation of atorvastatin calcium and fenofibrate in tablets by derivative spectrophotometry and liquid chromatography. Nakarani NV; Bhatt KK; Patel RD; Bhatt HS J AOAC Int; 2007; 90(3):700-5. PubMed ID: 17580622 [TBL] [Abstract][Full Text] [Related]
11. Spectroscopic characterization and quantitative determination of atorvastatin calcium impurities by novel HPLC method. Gupta LK Spectrochim Acta A Mol Biomol Spectrosc; 2012 Nov; 97():495-501. PubMed ID: 22842103 [TBL] [Abstract][Full Text] [Related]
12. In vitro availability of atorvastatin in presence of losartan. Arayne MS; Sultana N; Haroon U; Qureshi F; Ali SA Pak J Pharm Sci; 2006 Apr; 19(2):134-41. PubMed ID: 16751125 [TBL] [Abstract][Full Text] [Related]
13. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. Mohammadi A; Rezanour N; Ansari Dogaheh M; Ghorbani Bidkorbeh F; Hashem M; Walker RB J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):215-21. PubMed ID: 17010681 [TBL] [Abstract][Full Text] [Related]
14. An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets. Ertürk S; Sevinç Aktaş E; Ersoy L; Fiçicioğlu S J Pharm Biomed Anal; 2003 Dec; 33(5):1017-23. PubMed ID: 14656592 [TBL] [Abstract][Full Text] [Related]
15. Three different methods for determination of binary mixture of Amlodipine and Atorvastatin using dual wavelength spectrophotometry. Darwish HW; Hassan SA; Salem MY; El-Zeany BA Spectrochim Acta A Mol Biomol Spectrosc; 2013 Mar; 104():70-6. PubMed ID: 23266678 [TBL] [Abstract][Full Text] [Related]
16. RP-HPLC ANALYSIS OF ACIDIC AND BASIC DRUGS IN SYSTEMS WITH DIETHYLAMINE AS ELUENTS ADDITIVE. Petruczynik A; Wroblewski K; Strozek S; Waksmundzka-Hajnos M Acta Pol Pharm; 2016 Nov; 73(6):1475-1485. PubMed ID: 29634101 [TBL] [Abstract][Full Text] [Related]
17. An improved HPLC method with the aid of a chemometric protocol: simultaneous analysis of amlodipine and atorvastatin in pharmaceutical formulations. Sivakumar T; Manavalan R; Muralidharan C; Valliappan K J Sep Sci; 2007 Dec; 30(18):3143-53. PubMed ID: 18027357 [TBL] [Abstract][Full Text] [Related]
18. DFT study on hydroxy acid-lactone interconversion of statins: the case of atorvastatin. Hoffmann M; Nowosielski M Org Biomol Chem; 2008 Oct; 6(19):3527-31. PubMed ID: 19082153 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous estimation of atorvastatin and ramipril by RP-HPLC and spectroscopy. Joseph L; George M; Rao B VR Pak J Pharm Sci; 2008 Jul; 21(3):282-4. PubMed ID: 18614425 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of atorvastatin calcium and olmesartan medoxomil in a pharmaceutical formulation by reversed phase high-performance liquid chromatography, high-performance thin-layer chromatography, and UV spectrophotometric methods. Soni H; Kothari C; Khatri D; Mehta P J AOAC Int; 2014; 97(3):791-7. PubMed ID: 25051627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]